AveXis Company

AveXis is a Biotech company is focused on developing gene therapy for patients with rare and life-threatening neurological genetic diseases.
Industry:
Gene Therapy
Technology:
Rare Genetic Disorders
Funding Status:
M&A
Estimated Revenue:
$1B to $10B
Headquarters:
Dallas, Texas, United States
Founded Date:
2013